Pixium Vision Announces the First Successful Implantation and Activation of IRISĀ® II, 150 Electrode Bionic Vision System, in the UK

PARIS & LONDON–(BUSINESS WIRE)–Regulatory News: Pixium Vision (Paris:PIX) (FR0011950641 – PIX, “Pixium”), a company developing innovative bionic vision systems with the intention to allow patients who have lost their sight to lead more independent lives, announces the first successful implantation and activation of IRIS® II in the UK. This epi-retinal implant with 150 electrodes is intended for patients who have lost sight as a result of retinitis pigmentosa (RP). The first implant of IRIS® I


Data monitoring key to tracking, improving toric IOL outcomes

NEW YORK — Keeping extensive records of accuracy, tracking outcomes and measuring accurately are key to improving surgical outcomes after toric IOL implantation and reducing the need for enhancement following the procedure, according to a speaker here. “You want to automate as much as possible,” Denise M. Visco, MD, said at the OSN New York meeting. “It’s critical that if you put a lot of effort into measuring, you need to put a lot of effort into marking. You want to track your results and go in the direction of (Read more...)

Non-IV sedation eases anxiety for patients undergoing cataract surgery

NEW YORK — Patients who received sublingual anesthesia prior to cataract surgery had less anxiety than those who underwent an intravenous form of anesthesia for cataract surgery, according to a presenter here.“Sublingual sedation approaches decrease the need for IVs. You get a predictable dosing, …it allows a sublingual administration, patients really like it, and you get a little bit better focusing on the light and a ketamine stare,” John P. Berdahl, MD, said at the OSN New York meeting.